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*Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-25011, U.S.A., and
Biochemical Pharmacology Branch, U. S. Army Medical Research Institute of Chemical Defense, APG,
MD 21010-25400, U.S.A.
This investigation examined the utility of three re-
combinant protein-expression systems (COS cells,
insect cells and insect larvae) to cost-effectively pro-
duce biologically active human butyrylcholinesterase
(BuChE). It was determined that baculovirus-infected
insect cells (Sf9 and High 5) expressed 3.5- and 8.2-fold,
respectively, more active enzyme than COS-7 cells.
Baculovirus-infected cabbage looper (Trichoplusia ni)
insect larvae produced over 26 times more than High 5
cells ; in fact, one baculovirus-infected insect larva
provided more active protein than 100 ml of insect cell
culture. Analysis of the larvally expressed proteins
revealed that the vast majority of BuChE expressed was
inactive due to extensive degradation that occurred in
vivo. However, the active form of BuChE does have
enzyme kinetics similar to those of its human serum
counterpart. Cabbage looper larvae were also ex-
amined for their ability to serve as an in vivo animal
model to study protection against anti-cholinesterase
toxicity. This was unsuccessful due to their high
tolerance to the very toxic organophosphorus com-
pounds tested. This tolerance may be attributed at
least in part to a novel endogenous organophosphorus
acid anhydride hydrolase activity that is capable
of hydrolysing the chemical-warfare nerve agents
sarin (isopropyl methylphosphonofluoridate) and
soman (pinacolyl methylphosphonofluoridate). These
results show that cabbage looper larvae can serve
as an inexpensive recombinant protein-expression
system for human BuChE.
Introduction
The cholinesterases and carboxylesterases are a multi-gene
family of enzymes that hydrolyse a diverse group of
carboxylesters. Enzymes of this family are inhibited irrever-
sibly by many organophosphorus (OP) nerve agents and
insecticides [1,2]. The most studied and critical of these
events is the inhibition of enzyme acetylcholinesterase
(AChE, EC 3.1.1.7) by chemical-warfare nerve agents, such
as sarin (isopropyl methylphosphonofluoridate, or GB),
soman (pinacolyl methylphosphonofluoridate, or GD) and
VX †O-ethyl S-[2-[bis(1-methylethyl)amino]ethyl]methyl
phosphonothiolate·. Inhibition of AChE, which resets the
cholinergic system by hydrolysing the neurotransmitter
acetylcholine [3], results in loss of neuronal function,
paralysis and, soon thereafter, death. It has been shown that
the serum enzyme butyrylcholinesterase (BuChE, EC 3.1.1.8)
can serve as a scavenger in vivo to stoichiometrically bind
the OPs prior to the inhibition of synaptic AChE [4]. This
stoichiometric scavenger (one molecule of scavenger reacts
with one molecule of OP) approach has proven effective but
requires a large amount of material to destroy a small
amount of OP. Catalytic scavengers (one molecule of
scavenger reacts with many molecules of OP) have also been
investigated, but the enzymes found thus far in Nature are
generally inefficient ; they have high Km values and low
turnover numbers [5]. Through site-directed mutagenesis of
the human BuChE cDNA we have created novel organo-
phosphorus acid anhydride hydrolases (OPAHs) that are
capable of performing as catalytic scavengers in vitro [6] ;
however, there have been insufficient quantities of these
enzymes to perform studies in vivo. All of these OP-
scavenging studies have been limited because they require
significant amounts of active recombinant protein, which are
currently unobtainable.
To find more efficient and productive recombinant
human (rh)BuChE expression systems three eukaryotic
systems were examined. Considerations included ease of
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use, cost, and quantity and quality of the BuChE produced.
The systems analysed included two conventional cell-culture
systems (COS and insect cells) and a third, unconventional,
approach utilizing baculovirus-infected cabbage looper (Tri-
choplusia ni) insect larvae. The COS cell system was initially
selected due to its ease of use, reasonable cost and speed in
expressing mutant forms of recombinant proteins. The
baculovirus system [Autographa californica nuclear poly-
hedrosis virus (AcNPV)] has been shown to be useful for the
expression in vitro of many eukaryotic proteins and is
generally regarded as highly efficient. In addition, most of the
recombinant proteins expressed in this system have been
found to be similar to their native counterparts in bioactivity,
immunoactivity and conformation [7]. Nevertheless, some
problems remain with baculovirus-expressed proteins, no-
tably glycosylation patterns, which could impact the ex-
pression of the BuChE glycoprotein. Based on reports that
other human enzymes have been produced at high levels in
T. ni [8,9], we postulated that the intact animal would be
more likely to produce a fully glycosylated product, though
not necessarily with a mammalian pattern, and at higher
concentrations than that expressed by insect cell culture.
Further, a high concentration of BuChE in an intact animal
might efficiently scavenge OP cholinesterase inhibitors, when
challenged, and thereby confer protection in vivo from
insecticides and nerve agents. Hence, the recombinant
BuChE–AcNPV-infected larvae might also adequately serve
as a useful model to test the efficacy of bioscavengers to
protect against OP toxicity. This study has led to the
discovery of a novel cabbage looper OPAH.
Materials and methods
Cells, larvae and virus
COS-7 cells were purchased from ATCC (Rockville, MD,
U.S.A.). Insect cells (Spodoptera frugiperda Sf9 cells and T. ni
High 5 cells) and wild-type (wt)-AcNPV were purchased
from Invitrogen (San Diego, CA, U.S.A.). Fourth- or fifth-
instar cabbage looper larvae and all entomological supplies
were purchased from EntoPath (Easton, PA, U.S.A.). The
BuChE–AcNPV baculovirus was the generous gift of Dr
Oksana Lockridge (University of Nebraska Medical Center,
Omaha, NE, U.S.A.).
Production of (rh)BuChE in COS-7 cells, insect cells
and cabbage looper larvae
COS-7 cell expression Qiagen-purified plasmid DNA con-
taining the human wt-BuChE cDNA cloned into the vector
pRcCMV (Invitrogen) was used to transfect COS-7 cells by
the DEAE-dextran method [10]. Following transfection, cells
were grown in 5% CO2 at 37 °C in Dulbecco’s modified
Eagles ’s medium (Life Technologies, Grand Island, NY,
U.S.A.) supplemented with 10% fetal bovine serum. After
24 h, medium was removed, and cells were washed with
Hank ’s balanced salt solution and incubated for an additional
60 h in Opti-MEM I reduced-serum medium (Life Tech-
nologies). Control medium was prepared by culturing non-
transfected cells under identical conditions. Harvested
medium was centrifuged at 2300 g and concentrated by
ultrafiltration.
High 5 and Sf9 expression The BuChE–AcNPV consisted
of the human wt-BuChE cDNA placed downstream of the
polyhedrin promoter (O. Lockridge, personal communi-
cation) and was amplified to high titres using conventional
procedures [7]. High-titre BuChE–AcNPV (multiplicity of
infection, 10) was used to infect 3.0‹106 Sf9 or High 5
cells. Monolayer cultures were grown in Sf-900 II serum-
free medium (Life Technologies) at 27 °C for 84 h.
Control medium was prepared by culturing wt-AcNPV-
infected (multiplicity of infection, 10) and -uninfected insect
cells under identical culture conditions. After harvesting,
media were centrifuged at 2300 g, concentrated by ultrafil-
tration and assayed for BuChE activity.
Insect larval expression T. ni larvae, late in the fourth instar,
were infected either by mouth or by direct injection.
Infection by mouth involved growing the larvae for E 72 h at
30 °C on synthetic medium overlayed with 300 ll of high-
titre BuChE–AcNPV or wt-AcNPV. Alternatively, 5 ll of the
BuChE–AcNPV or wt-AcNPV was injected with a syringe
and the larvae allowed to grow on synthetic medium for 72 h
at 30 °C. Harvesting involved homogenizing the larvae in
150 mM NaCl either alone or with a protease-inhibitor
cocktail (1 mg}ml EDTA, 0.1 mg}ml (4-amidinophenyl)me-
thanesulphonyl fluoride (APMSF), 0.3 mg}ml E-64, 0.5 lg}ml
leupeptin, 0.1 mg}ml soya bean trypsin inhibitor in PBS,
pH 7.4). This was followed by centrifugation at 14000 g for
20 min at 4 °C. The resulting supernatant devoid of hae-
mocytes and cell debris was transferred to a new tube and
analysed immediately or stored at 4 °C.
Insect larval animal model Cabbage looper larvae late in the
fourth instar were infected by injecting 5 ll of the high-titre
BuChE–AcNPV or wt-AcNPV as described above. Larvae
were grown on synthetic medium for approximately 72 h at
30 °C and challenged with the chemical-warfare OP nerve
agents soman or VX. The challenge was performed either by
placing larvae on a 60-mm petri dish saturated with 11 mM
soman or 3.5 mM VX or by directly injecting 5 ll of the OP
into the larva. The time of death of each larva was measured
for BuChE–AcNPV, wt-AcNPV and uninfected controls.
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Analysis of expressed proteins
SDS}PAGE was performed in 7.5% polyacrylamide gels
using the buffer system of Laemmli [11]. Immunoblotting of
nitrocellulose-immobilized proteins was performed follow-
ing standard procedures, probed with rabbit anti-human
BuChE and visualized with goat anti-rabbit IgG horseradish
peroxidase. (rh)BuChE enzyme activity was confirmed by
staining 7.5% non-denaturing polyacrylamide gels with 1 mM
butyrylthiocholine (BuSCh ; Sigma, St. Louis, MO, U.S.A.)
following the method of Karnovsky and Roots [12]. The
molecular mass of the endogenous T. ni OPAH activity was
determined by applying larval homogenates and known
molecular-mass standards (horseradish peroxidase and Tor-
pedo californica AChE) to a TSK-GEL 2000 SW gel-filtration
column (Supelco, Bellefonte, PA, U.S.A.) and collecting
fractions. Proteins were eluted from the column with
150 mM NaCl, pH 7.0, and analysed for activity as described
below.
Kinetic assays
Michaelis–Menten constants (Km) of (rh)BuChE expressed in
larvae were determined for the substrates BuSCh and
acetylthiocholine (Sigma) using a variation of the Ellman
method [13], modified for use in a microtitre plate reader.
Briefly, 50 ll of the sample to be tested was placed into each
well in a row of wells of a microtitre plate. In another row,
the first well was filled with 200 ll of a high concentration
(usually 1 mM) of substrate containing 0.22 mM 5,5«-dithio-
bis(2-nitrobenzoic acid) in 0.1 M phosphate buffer, pH 8.0, at
25 °C. To each of the remaining wells in the row 100 ll of
the phosphate buffer was added, and a series of dilutions was
made by pipetting 100 ll of the contents of the first well into
the second, mixing, transferring 100 ll of that solution to the
next, mixing, transferring 100 ll of that solution to the next
and so on to the end of the row. Then, using a multiple
pipettor the contents of the entire row were transferred to
the row containing the enzyme sample and mixed; the plate
was placed in the microtitre plate reader and assayed in the
‘kinetics ’ mode. In this manner reaction rates were obtained
for a large range of substrate concentrations simultaneously
under the same reaction conditions.
OPAH activity of the potential substrates soman, sarin
and tabun (ethyl dimethylphosphoramidocyanidate, or GA)
was measured in a pH stat (Radiometer, Copenhagen,
Denmark) using 2 ml of a 1 mM solution of the test
compound in 150 mM NaCl. The activity against VX and
echothiophate †2-[(diethoxy phosphinyl)thio]-N,N,N-tri-
methyl ethanaminium· was measured in a microtitre plate
using a variation of the Ellman method described above, with
the OP compound replacing the BuSCh as substrate. The
hydrolysis of paraoxon (O,O-diethyl p-nitrophenyl phos-
phate) was followed by measuring the release of p-nitro-
phenol spectrophotometrically at 405 nm, usually in a
microtitre plate reader. All chemical-warfare nerve agents
(tabun, sarin, soman and VX) were obtained from the
Edgewood Chemical and Biological Center (ECBC), Aber-
deen Proving Ground, MD, U.S.A., and determined by gas
chromatography to be " 98% pure. These agents are
extremely toxic and were handled according to established
regulations governing chemical-warfare surety materials.
Results and discussion
This project was designed to examine the ability of three
expression systems to cost-effectively overexpress bio-
logically active human BuChE. It was determined that
baculovirus-infected insect cells (Sf9 and High 5) expressed
3.5- and 8.2-fold, respectively, more active enzyme than
COS-7 cells. However, based on the activity per unit volume
of the larval homogenates, the production of BuChE activity
by baculovirus-infected T. ni larvae far surpassed all three of
the cell culture lines, expressing more than 26 times that of
the High 5 cell media. In fact, one baculovirus-infected insect
larva produced more active BuChE than 100 ml of infected
insect cell-culture medium. This equates in cost to US$0.05
for the larva versus E $5.00 for 100 ml of the medium, a
saving of well over 100-times when one includes the
additional expenses associated with maintaining the cell line
(i.e. sterile plasticware and medium, etc.).
Background levels of endogenous larval cholinesterase
were very limited based on Western blots (Figure 1, lane 6),
activity gel stains (Figure 2, lane 10) and kinetic assays of
controls (results not shown). As in humans, acetylcholine in
insects serves as a major excitatory neurotransmitter, so
this finding was not expected. This result may be due to the
larval cholinesterase being membrane-bound or to a signifi-
Figure 1 Western-blot analysis of insect larval homogenates
Lanes 1–3, 5, 1 and 15 units of BuChE ; lane 4, empty ; lane 5, 10 ll of infected
T. ni homogenate ; lane 6, 10 ll of uninfected T. ni homogenate.
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Figure 2 Activity gel stain of insect larval homogenates
Lanes 1–4, 15, 1.5, 9 and 0.15 units of BuChE ; lane 5, empty ; lanes 6 and 7, 1 ll
of infected larvae homogenate ; lanes 8 and 9, 10 ll of infected larvae
homogenate ; lane 10, 10 ll of uninfected T. ni homogenate.
cant dissimilarity between human BuChE and the larval
cholinesterase in shape and}or function. For example, work
on the Drosophila cholinesterase has shown that the insect
carries one enzyme that has intermediate features between
AChE and BuChE in its encoded protein sequence [14] as
well as its catalytic specificity [15].
An attempt to estimate the recombinant BuChE protein
concentration by immunoblotting resulted in a smear
indicative of extensive degradation of the majority of protein
recognized by anti-BuChE polyclonal antibody (Figure 1, lane
5). Homogenization of larvae in a protease-inhibitor cocktail
resulted in a similar smear, suggesting that the degradation
events occurred in vivo and not during harvesting. This
degraded protein is apparently inactive since native gels
stained for cholinesterase activity showed that the BuChE
activity was limited to a small high-molecular-mass stain at
the top of the gel (Figure 2, lane 6–10). However, whereas
the majority of the recombinant protein expressed was
inactive, the active species does have similar enzyme kinetics
to its human counterpart. Km values for acetylthiocholine and
BuSCh were determined to be 0.050 and 0.025 mM,
respectively, which are very similar to those of human
serum BuChE (0.043 and 0.0177 mM, respectively) [16].
The extensive degradation in vivo observed here may
largely be due to the process of N-linked glycosylation in
insects differing from that in mammals [7]. Human BuChE is
heavily N-glycosylated (23.9% by weight [17,18]) with at
least nine out of ten potential N-linkage sites carrying an
oligosaccharide chain [19]. It seems plausible that altered
glycosylation may cause improper folding of the macro-
molecule, resulting in a general lack of secretion, build-up of
high intracellular levels leading to inclusion bodies and
heightened protease susceptibility.
The toxicities of the chemical-warfare OP nerve agents
soman and VX in T. ni were also examined to determine
whether the overexpressed (rh)BuChE could enhance
survivability. No significant difference was found between
the BuChE–AcNPV-infected, wt-AcNPV-infected or the
uninfected larva controls (results not shown). However,
the cabbage looper was found naturally to possess a high
resistance to these compounds. Larvae survived for several
hours when exposed to 11 mM soman or 3.5 mM VX by
contact, but only for several minutes when injected directly
with the OP. When lower concentrations of nerve agent
were injected, survival times were extended, to E 15 min
for 5.5 mM soman and 1.755 mM VX and to several hours
for both OPs at 1 mM. The absence of enhanced survivability
by the overexpression of BuChE–AcNPV larvae was prob-
ably due to the very small amount of OP that can be
stoichiometrically scavenged by the active form of the BuChE
compared with the high lethal dose of the agents in T. ni.
Subsequent experiments focused on why the cabbage
looper larvae have such a high tolerance to the highly toxic
OPs. Homogenates of uninfected T. ni larva were analysed
for the ability to hydrolyse soman and VX and several other
anti-cholinesterases. It was determined that the larvae
contained an enzyme(s) capable of hydrolysing soman and
sarin but not VX, tabun, echothiophate or paraoxon.
Apparently the novel OPAH possesses the ability to
hydrolyse the P–F bond found in the phosphorus centre of
soman and sarin but not the P–CN, p-nitrophenol or P–S
bonds found in tabun, paraoxon or VX, and echothiophate,
respectively. Characterization of the T. ni OPAH revealed
that soman was hydrolysed E 1.44 times faster than sarin
and that this activity was enhanced by the addition of
manganese, but not calcium, in the assay mixture. Further,
size fractionation revealed that this OPAH has a molecular
mass similar to that of tetrameric T. californica AChE and a
dissimilar mobility to the endogenous T. ni carboxylesterase.
The observed larval tolerance to VX cannot be explained
based by an endogenous OPAH activity but instead may
result from mechanisms similar to those reported to cause
heightened insect resistance to OP insecticides [20].
It is concluded that the cabbage looper larvae system
may be an economical means of overproducing recombinant
BuChE and other proteins in a eukaryotic system.
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